Federal Register / Vol. 72, No. 25 / Wednesday, February 7, 2007 / Notices 5723 

20201), Conference Room 4090 (please 

bring photo ID for entry to a Federal 

building). 

FOR FURTHER INFORMATION CONTACT: 

http://www.hhs.gov/healthit/ahic/ 

confidentiality/. 

SUPPLEMENTARY INFORMATION: The 

Workgroup members will discuss 

supplemental Identity Proofing 

Recommendations and Workgroup 

priorities for the rest of the year. The 

Workgroup plans to publish questions 

for public comment in the Federal 

Register before this meeting. 

This meeting will be available via 

Web cast at http://www.hhs.gov/ 

healthit/ahic/cps_instruct.html. 

Dated: January 30, 2007. 

Judith Sparrow, 

Director, American Health Information 

Community, Office of Programs and 

Coordination, Office of the National 

Coordinator for Health Information 

Technology. 

[FR Doc. 07–514 Filed 2–6–07; 8:45 am] 

BILLING CODE 4150–24–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the National Coordinator for 

Health Information Technology; 

American Health Information 

Community Personalized Healthcare 

Workgroup Meeting 

ACTION: Announcement of meeting. 

SUMMARY: This notice announces the 

2nd meeting of the American Health 

Information Community Personalized 

Healthcare Workgroup in accordance 

with the Federal Advisory Committee 

Act (Pub. L. No. 92–463, 5 U.S.C., App.). 

DATES: February 21, 2007, from 1 p.m. 

to 3 p.m. 

ADDRESSES: Mary C. Switzer Building 

(330 C Street, SW., Washington, DC 

20201), Conference Room 4090 (please 

bring photo ID for entry to a Federal 

building). 

FOR FURTHER INFORMATION CONTACT: 

http://www.hhs.gov/healthit/ahic/ 

healthcare/. 

SUPPLEMENTARY INFORMATION: The 

Workgroup will discuss standards for 

personalized healthcare and upcoming 

visioning exercise. For additional 

information, go to http://www.hhs.gov/ 

healthit/ahic/healthcare/ 

phc_instruct.html. 

Dated: January 29, 2007. 

Judith Sparrow, 

Director, American Health Information 

Community, Office of Programs and 

Coordination, Office of the National 

Coordinator for Health Information 

Technology. 

[FR Doc. 07–515 Filed 2–6–07; 8:45 am] 

BILLING CODE 4150–24–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the National Coordinator for 

Health Information Technology, 

American Health Information 

Community Electronic Health Records 

Workgroup Meeting 

ACTION: Announcement of meeting. 

SUMMARY: This notice announces the 

13th meeting of the American Health 

Information Community Electronic 

Health Records Workgroup in 

accordance with the Federal Advisory 

Committee Act (Pub. L. No. 92–463, 5 

U.S.C., App.). 

DATES: February 22, 2007, from 1 p.m. 

to 4 p.m./Eastern. 

ADDRESSES: Mary C. Switzer Building 

(330 C Street, SW., Washington, DC 

20201), Conference Room 4090 (please 

bring photo ID for entry to a Federal 

building). 

FOR FURTHER INFORMATION CONTACT: 

http://www.hhs.gov/healthit/ahic/ 

healthrecords/. 

SUPPLEMENTARY INFORMATION: The 

workgroup will continue its discussion 

of the barriers and drivers of EHR 

adoption. For additional information, go 

to http://www.hhs.gov/healthit/ahic/ 

healthrecords/ehr_instruct.html. 

Dated: January 29, 2007. 

Judith Sparrow, 

Director, American Health Information 

Community, Office of Programs and 

Coordination, Office of the National 

Coordinator for Health Information 

Technology. 

[FR Doc. 07–516 Filed 2–6–07; 8:45 am] 

BILLING CODE 4150–24–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

Anesthetic and Life Support Drugs 

Advisory Committee; Notice of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). The meeting will be open to the 

public. 

Name of Committee: Anesthetic and 

Life Support Drugs Advisory 

Committee. 

General Function of the Committee: 

To provide advice and 

recommendations to the agency on 

FDA’s regulatory issues. 

Date and Time: The meeting will be 

held on March 29, 2007, from 8 a.m. to 

5 p.m. 

Location: Doubletree Hotel & 

Executive Meeting Center, 1750 

Rockville Pike, Rockville, MD. The hotel 

telephone number is 301–468–1100. 

Contact Person: Cathy A. Groupe, 

Center for Drug Evaluation and Research 

(HFD–21), Food and Drug 

Administration, 5600 Fishers Lane (for 

express delivery, 5630 Fishers Lane, rm. 

1093), Rockville, MD 20857, 301–827–

7001, FAX: 301–827–6776, e-mail: 

Cathy.Groupe@fda.hhs.gov, or FDA 

Advisory Committee Information Line, 

1–800–741–8138 (301–443–0572 in the 

Washington, DC area), code 

3014512529. Please call the information 

line for up-to-date information on this 

meeting. 

Agenda: The committee will do the 

following: (1) Receive presentations 

regarding neurodegenerative findings in 

juvenile animals exposed to anesthetic 

drugs (e.g., ketamine); and (2) discuss 

the relevance of these findings to 

pediatric patients and provide guidance 

for future preclinical and clinical 

studies. 

FDA intends to make background 

material available to the public no later 

than 1 business day before the meeting. 

If FDA is unable to post background 

material on its Web site prior to the 

meeting, the background material will 

be made publicly available at the 

location of the advisory committee 

meeting, and the background material 

will be posted on FDA’s Web site after 

the meeting. Background material is 

available at http://www.fda.gov/ohrms/ 

dockets/ac/acmenu.htm, click on the 

year 2007 and scroll down to the 

appropriate advisory committee link. 

Procedure: Interested persons may 

present data, information, or views, 

orally or in writing, on issues pending 

before the committee. Written 

submissions may be made to the contact 

person on or before March 15, 2007. 

Oral presentations from the public will 

be scheduled between approximately 1 

p.m. to 2 p.m. Those desiring to make 

formal oral presentations should notify 

the contact person and submit a brief 

statement of the general nature of the 

evidence or arguments they wish to 

present, the names and addresses of 


sroberts on PROD1PC70 with NOTICES